FI962341A0 - Nya substituerade oxazolidiner - Google Patents

Nya substituerade oxazolidiner

Info

Publication number
FI962341A0
FI962341A0 FI962341A FI962341A FI962341A0 FI 962341 A0 FI962341 A0 FI 962341A0 FI 962341 A FI962341 A FI 962341A FI 962341 A FI962341 A FI 962341A FI 962341 A0 FI962341 A0 FI 962341A0
Authority
FI
Finland
Prior art keywords
pct
date jun
sec
compounds
substituted oxazolidines
Prior art date
Application number
FI962341A
Other languages
English (en)
Finnish (fi)
Other versions
FI962341A (sv
FI119987B (sv
Inventor
Alfred Sallmann
Hans-Peter Gschwind
Eric Francotte
Original Assignee
Ciba Geigy Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ciba Geigy Ag filed Critical Ciba Geigy Ag
Publication of FI962341A0 publication Critical patent/FI962341A0/sv
Publication of FI962341A publication Critical patent/FI962341A/sv
Application granted granted Critical
Publication of FI119987B publication Critical patent/FI119987B/sv

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D263/00Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings
    • C07D263/02Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings
    • C07D263/04Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings having no double bonds between ring members or between ring members and non-ring members
    • C07D263/06Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings having no double bonds between ring members or between ring members and non-ring members with hydrocarbon radicals, substituted by oxygen atoms, attached to ring carbon atoms
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00Drugs for disorders of the respiratory system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00Drugs for disorders of the respiratory system
    • A61P11/06Antiasthmatics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00Drugs for dermatological disorders
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/04Centrally acting analgesics, e.g. opioids
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00Drugs for immunological or allergic disorders
    • A61P37/08Antiallergic agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pulmonology (AREA)
  • Pain & Pain Management (AREA)
  • Neurosurgery (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Immunology (AREA)
  • Rheumatology (AREA)
  • Dermatology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
  • Saccharide Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Plural Heterocyclic Compounds (AREA)
FI962341A 1993-12-10 1996-06-05 Förfarande för framställning av nya substituerade oxazolidiner FI119987B (sv)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
CH369193 1993-12-10
CH369193 1993-12-10
PCT/EP1994/003937 WO1995015953A1 (en) 1993-12-10 1994-11-28 Novel substituted oxazolidines
EP9403937 1994-11-28

Publications (3)

Publication Number Publication Date
FI962341A0 true FI962341A0 (sv) 1996-06-05
FI962341A FI962341A (sv) 1996-06-05
FI119987B FI119987B (sv) 2009-05-29

Family

ID=4261454

Family Applications (1)

Application Number Title Priority Date Filing Date
FI962341A FI119987B (sv) 1993-12-10 1996-06-05 Förfarande för framställning av nya substituerade oxazolidiner

Country Status (14)

Country Link
US (1) US5635524A (sv)
EP (1) EP0733047B1 (sv)
JP (1) JP3792713B2 (sv)
KR (1) KR100354528B1 (sv)
AT (1) ATE171169T1 (sv)
AU (1) AU692809B2 (sv)
CA (1) CA2177171C (sv)
DE (1) DE69413417T2 (sv)
ES (1) ES2121621T3 (sv)
FI (1) FI119987B (sv)
HU (1) HU221500B (sv)
NO (1) NO306463B1 (sv)
NZ (1) NZ276421A (sv)
WO (1) WO1995015953A1 (sv)

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4064257A (en) * 1976-07-19 1977-12-20 Syntex (U.S.A.) Inc. Thiazole cardiovascular agents
ZW6584A1 (en) * 1983-04-18 1985-04-17 Glaxo Group Ltd Phenethanolamine derivatives
IE903614A1 (en) * 1989-10-10 1991-04-24 Glaxo Group Ltd Phenethanolamine Compound

Also Published As

Publication number Publication date
KR100354528B1 (ko) 2002-12-18
HU221500B (en) 2002-10-28
EP0733047A1 (en) 1996-09-25
WO1995015953A1 (en) 1995-06-15
CA2177171C (en) 2006-01-17
AU1068395A (en) 1995-06-27
DE69413417D1 (de) 1998-10-22
NO962424D0 (no) 1996-06-07
ATE171169T1 (de) 1998-10-15
NO962424L (no) 1996-06-07
FI962341A (sv) 1996-06-05
DE69413417T2 (de) 1999-03-04
NZ276421A (en) 1998-01-26
JPH09506357A (ja) 1997-06-24
CA2177171A1 (en) 1995-06-15
AU692809B2 (en) 1998-06-18
EP0733047B1 (en) 1998-09-16
JP3792713B2 (ja) 2006-07-05
FI119987B (sv) 2009-05-29
US5635524A (en) 1997-06-03
HU9601585D0 (en) 1996-08-28
HUT74689A (en) 1997-01-28
ES2121621T3 (es) 1998-12-01
NO306463B1 (no) 1999-11-08

Similar Documents

Publication Publication Date Title
KR970704435A (ko) 헤테로시클릭 화합물의 도파민-D 리간드로서의 용도(Use of Heterocyclic Compounds as Dopamines-D Ligands)
DK0778834T3 (da) Bicykliske, heterocykliske diarylforbindelser som inhibitorer af cyclooxygenase-2
NO306345B1 (no) Piperidin-derivater med PAF antagonist-aktivitet, anvendelse derav og farmasöytisk blanding
ATE181731T1 (de) Isothioharnstoff-derivate als no synthase hemmer
ATE212996T1 (de) Anthracyclin-derivate
DE69512208D1 (de) Aminosäurederivate und ihre verwendung als phospholipase-a2-inhibitoren
FI962341A0 (sv) Nya substituerade oxazolidiner
DK0720598T3 (da) Phenoxyphenylcyclopentenyl-hydroxyurinstoffer
SE0104333D0 (sv) Therapeutic agents
CA2105215A1 (en) Novel oxazolidines
PT1082116E (pt) Utilizacao de derivados de 4-piperidinometanol no tratamento de desordens do neurodesenvolvimento
EP0292819A3 (en) 5-phenyl-1,2,3a,4,5,9b-hexahydro-3h-benzûe¨indoles, their preparation and use as medicaments
TH148527B (th) อนุพันธ์ไพราโซโล-ควินาโซลีน กระบวนการสำหรับการเตรียมสารนั้นและการใช้สารนั้นเป็นสารยับยั้งไคเนส

Legal Events

Date Code Title Description
GB Transfer or assigment of application

Owner name: NOVARTIS AG

FG Patent granted

Ref document number: 119987

Country of ref document: FI

MA Patent expired